NEW YORK, Dec. 29, 2017 /PRNewswire/ --
WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on OHI, HTA, HCN, and SBRA which can be accessed for free by signing up to http://www.wallstequities.com/registration. REITs are impacted by a number of changes in the new tax law, according to an article on Seeking Alpha. Changes to the treatment of pass-through entities, interest deductions, partnership terminations, and expensing all provide benefits to REITs, it further noted. Additionally, a range of beneficial credits and deductions already in use have also been preserved. The law will likely spur further investment in real estate, including REITs. Finally, the changes are not so great as to change the outlook for the sector in 2018, and REITs will likely remain in a defensive posture. This morning, WallStEquities.com covers four Healthcare Facilities REIT stocks, namely: Omega Healthcare Investors Inc. (NYSE : OHI ), Healthcare Trust of America Inc. (NYSE : HTA ), Welltower Inc. (NYSE : HCN ), and Sabra Health Care REIT Inc. (NASDAQ : SBRA ). All you have to do is sign up today for this free limited time offer, click the link below. http://www.wallstequities.com/registration
Omega Healthcare Investors
Maryland, US-based Omega Healthcare Investors Inc.'s shares gained 0.55%, closing Thursday's trading session at $27.50. The stock recorded a trading volume of 1.74 million shares. The Company's shares have advanced 2.12% in the last month. The stock is trading 3.02% below its 50-day moving average. Additionally, shares of the Company, which invests in the real estate markets of US, have a Relative Strength Index (RSI) of 45.53.
On December 21st, 2017, research firm Jefferies downgraded the Company's stock rating from 'Hold' to 'Underperform'. Get the full research report on OHI for free by clicking below at: http://www.wallstequities.com/registration/?symbol=OHI
Healthcare Trust of America
On Thursday, shares in Scottsdale, Arizona-based Healthcare Trust of America Inc. recorded a trading volume of 1.30 million shares, which was above their three months average volume of 1.14 million shares. The stock rose 0.07%, ending the day at $30.06. The Company's shares have advanced 0.84% in the previous three months and 3.26% on an YTD basis. The stock is trading slightly below its 50-day moving average by 0.97%. Furthermore, shares of the Company, which engages in acquiring, owning and operating high-quality medical office buildings located primarily on-campus or affiliated with the nation's leading healthcare systems, have an RSI of 44.16.
On December 13th, 2017, research firm Morgan Stanley upgraded the Company's stock rating from 'Equal-Weight' to 'Overweight'. HTA's complimentary research coverage is a few simple steps away at: http://www.wallstequities.com/registration/?symbol=HTA
Toledo, Ohio-based Welltower Inc.'s stock finished the day 0.71% higher at $63.72 with a total trading volume of 1.28 million shares. The stock is trading below their 50-day moving average by 4.84%. Shares of the Company, which engages in acquiring, planning, developing, managing, repositioning and monetizing of real estate assets, have an RSI of 33.58.
On December 27th, 2017, Welltower's CEO Tom DeRosa announced that the Company, in collaboration with Simon, a global leader in the ownership of premier shopping, dining, entertainment and mixed-use destinations, is bringing world-class outpatient care to The Shops at Mission Viejo in the form of a 105,000-square-foot rental outpatient center. This center will focus on cancer care, but will also include an array of health and medical services, in partnership with the local health system that has a hospital located adjacent to the site. Register for your free research report on HCN at: http://www.wallstequities.com/registration/?symbol=HCN
Sabra Health Care REIT
Shares in Irvine, California-based Sabra Health Care REIT Inc. ended yesterday's session 0.53% higher at $19.00. The stock recorded a trading volume of 955,240 shares. The Company's shares are trading 2.95% below their 50-day moving average. Moreover, shares of the Company, which operates as a REIT in the US, have an RSI of 44.45.
On December 21st, 2017, research firm Jefferies downgraded the Company's stock rating from 'Buy' to 'Hold'. Wall St. Equities' downloadable research report on SBRA available at: http://www.wallstequities.com/registration/?symbol=SBRA
Wall St. Equities:
Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
WSE has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third-party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email firstname.lastname@example.org. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit https://wallstequities.com/legal-disclaimer/
For any questions, inquiries, or comments reach out to us directly. If you're a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Phone number: +21-32-044-483
Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Wall St. Equities